Last month, Maxim shares spiked after CNBC reported talks for a potential $20B acquisition.
Renesas dismissed the reports at the time.
NAR says Maxim remains on the list but that the plan “entails some risks” as too high a price would force Renesas to book a "considerable amount" of goodwill that could dent operating profit.
Previously: Maxim Integrated +12.3% on acquisition target news (Jan. 29)
Previously: Renesas dismisses report on talks to buy Maxim (Jan. 30)
Subscribe for full text news in your inbox